There was significant anti-tumor activity against pancreatic cancer cell lines and xenograft tumor models expressing both CEA and MSLN, and there was a lack of T-cell activation in the presence of just one antigen. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.